Activation of G-protein-coupled receptor 39 reduces neuropathic pain in a rat model
Longqing Zhang(Tongji Hospital), Wei Mei(Tongji Hospital), Dai-Qiang Liu(Tongji Hospital), Shao‐Jie Gao(Tongji Hospital), Fan‐He Song(Tongji Hospital), Danyang Li(Qilu Hospital of Shandong University), Jia Sun(Union Hospital), Ya‐Qun Zhou(Tongji Hospital), Xi Tan(Tongji Hospital), Jiayi Wu(Tongji Hospital)
Cited by 18
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia
|Clinical Infectious Diseases|2020|138
PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
|Current Pharmaceutical Design|2017|126